ClinicalTrials.Veeva

Menu

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

A

Aarhus University Hospital

Status

Completed

Conditions

Platelet Activation
Intensive Care Units
Platelet Function Tests
Blood Platelets
Platelet Aggregation
Extracorporeal Membrane Oxygenation

Study type

Observational

Funder types

Other

Identifiers

NCT03355625
ECMO-Camilla

Details and patient eligibility

About

The primary aim is to describe platelet function in adult patients treated with extracorporeal membrane oxygenation (ECMO). A clarification of the platelet function in these critically ill patients contributes to an understanding of the mechanisms underlying their coagulopathy.

The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).

Full description

The knowledge of platelet function during extracorporeal membrane oxygenation (ECMO) remains sparse. In the present study, the aim is to investigate platelet function in adult patients treated with ECMO using flow cytometry. The investigators hypothesize that platelet function increases from day 1 to day 3 in patients treated with ECMO. The secondary aim is to investigate the association between platelet function and the incidence of bleeding episodes and thrombosis during ECMO treatment.

The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).

Enrollment

33 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Treatment with veno-venous or veno-arterial ECMO
  • Age ≥18 years

Exclusion criteria

  • ECMO treatment initiated post-operatively

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems